Gamma camera identifies precancerous breast cells

Article

Researchers at Duke University Medical Center have developed a breast scanner that identifies subtle changes in breast cells that may be an early sign of cancer. The modified gamma camera spots these changes before they are visible with screening

Researchers at Duke University Medical Center have developed a breast scanner that identifies subtle changes in breast cells that may be an early sign of cancer. The modified gamma camera spots these changes before they are visible with screening mammography, according to the Duke team.

The ultimate goal behind developing the device is to enable doctors to treat breast cancer less invasively and more successfully. The technology's developer concedes, however, that a marketable system may be several years off.

Work on the prototype began five years ago when Martin Tornai, Ph.D., an associate professor of radiology and biomedical engineering at Duke, combined a LumaGEM gamma camera from Gamma Medica of Northridge, CA, with high-precision positioning equipment and image reconstruction software. The result was a rotating gamma camera that orbits the breast, creating-after injection of a radiotracer-a high-resolution 3D image.

"With this compact camera, we can contour the breast and minimize degradation to the spatial resolution-a fundamental problem in SPECT," Tornai said. "This has never been done for dedicated breast imaging."

The system, which Tornai developed in collaboration with Duke colleagues James Bowsher and Caryl Brzymialkiewicz, creates a kind of functional mammotomogram that might be particularly useful in screening women with large or dense breasts, as well as those at high risk for developing breast cancer. It might be used to augment screening mammography, or to help monitor the course of both chemotherapy and radiation therapy by detecting changes to the cancer cells.

"The sooner you can diagnostically identify that a person may be developing cancer, the quicker you can get her into the appropriate treatment regimen," Tornai said.

Tornai wants to market the device, but not before clinical trials have proven its effectiveness. The Duke researcher is hoping to begin testing soon. He predicted the price of a marketable product would be competitive with that of a screening mammography system.

"We are discussing (the development of a marketable product) with some companies," he said. "Others are looking into dedicated breast imaging using clinical gamma cameras, as we have in the past, but no one else does it compactly and in 3D like we do."

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.